Publikationen in Zusammenarbeit mit Forschern von Hospital General Universitario Gregorio Marañón (82)

2024

  1. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

  2. The incidence of HIV-2 infection in Spain is declining – a registry data analysis

    International Journal of Infectious Diseases, Vol. 146

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Journal of Clinical Virology, Vol. 167

  3. Determinants of poor clinical outcome in patients with influenza pneumonia: A systematic review and meta-analysis

    International Journal of Infectious Diseases, Vol. 131, pp. 173-179

  4. HTLV-1-associated myelopathy in Spain

    Journal of Clinical Virology, Vol. 169

  5. Impact of potent nucleos(t)ide therapy on hepatitis B hospitalisations in Spain

    Alimentary Pharmacology and Therapeutics, Vol. 57, Núm. 5, pp. 540-548

  6. Impact of the COVID-19 pandemic on hospital admissions due to viral hepatitis in Spain

    Journal of Clinical Virology, Vol. 167

  7. Spatial and temporal analysis of invasive pneumococcal disease due to erythromycinresistant serotypes

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 2, pp. 92-98

2022

  1. Hepatitis C hospitalizations in Spain and impact of new curative antiviral therapies

    Journal of Viral Hepatitis, Vol. 29, Núm. 9, pp. 777-784

  2. Late presentation of human T-lymphotropic virus type 1 infection in Spain reflects suboptimal testing strategies: on behalf of the Human T-lymphotropic Virus (HTLV) Spanish Network

    International Journal of Infectious Diseases, Vol. 122, pp. 970-975

  3. Liver cancer and hepatic decompensation events in patients hospitalized with viral hepatitis in Spain

    Hepatology International, Vol. 16, Núm. 5, pp. 1161-1169

  4. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. Hepatitis delta in patients hospitalized in Spain (1997-2018)

    AIDS (London, England), Vol. 35, Núm. 14, pp. 2311-2318

2019

  1. Association of HTR2A-1438G/A Genetic Polymorphism With Smoking and Chronic Obstructive Pulmonary Disease

    Archivos de Bronconeumologia, Vol. 55, Núm. 3, pp. 128-133

  2. Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 74, Núm. 5, pp. 1357-1362

  3. Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain

    Open Forum Infectious Diseases, Vol. 6, Núm. 2

  4. Local prevalence of extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae intestinal carriers at admission and co-expression of ESBL and OXA-48 carbapenemase in Klebsiella pneumoniae: A prevalence survey in a Spanish University Hospital

    BMJ Open, Vol. 9, Núm. 3

  5. Predictors of hepatitis C treatment failure after using direct-acting antivirals in people living with human immunodeficiency virus

    Open Forum Infectious Diseases, Vol. 6, Núm. 3

2018

  1. Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study

    Open Forum Infectious Diseases, Vol. 5, Núm. 1